TCR CURE Biopharma is a company that develops cancer immunotherapies. It focuses on antigen-specific TCR cloning, industry-scale virus production, T cell genetic engineering, and immune cell manufacturing. The company has several pipelines of TCR-T cell therapy products for solid tumors, including cervical cancer, nasopharyngeal carcinoma, head and neck cancer, lung squamous carcinoma, colorectal cancer, ovarian cancer, multiple myeloma, and brain cancer.